Taken together, these data provide more insights about the variants at the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster as a relevant risk factor for dyslipidemias such as HTG and low HDL-C, and highlight the notion that these could be biomarkers for susceptibility to these traits. This evidence concerns the gene APOA1 and metabolic syndrome.